Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Danish Center for AI Innovation (DCAI) is a specialized company established to house and operate "Gefion," one of the world's most powerful AI supercomputers. Launched in 2024 through a collaboration between the Novo Nordisk Foundation, the Export and Investment Fund of Denmark (EIFO), and NVIDIA, the center aims to accelerate breakthroughs in life sciences, drug discovery, and biotechnology. By providing large-scale computational power, DCAI enables researchers from academia and industry to tackle complex challenges in protein design, disease modeling, and climate change. The center serves as a national hub for AI-driven innovation, fostering a robust ecosystem for the Danish and international scientific communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danish Center for AI Innovation.